GeneralBreaking NewsBreakingLatest News
Keralam Orders Probe into Use of Expired Remdesivir on Nipah Patients
Sentiment: NeutralHigh Priority
What Happened?
Keralam has initiated an inquiry into the alleged administration of expired Remdesivir to Nipah patients. The investigation will assess potential patient harm and procurement issues.
Key points
- Keralam's Health Minister K Muraleedharan announced an expert committee to investigate the use of expired Remdesivir.
- The inquiry will check if expired doses caused any patient deaths or adverse effects.
- Remdesivir procured in 2021 expired in May 2023 but may have been used until 2025.
- The investigation will also look into the procurement process and the role of intermediaries.
- Muraleedharan confirmed that the quality of Remdesivir is not in question, only its expiry status.
- The Kerala Medical Services Corporation Limited last procured 3,000 vials of Remdesivir for Rs 42 lakh in June 2021.
Key insights
- The findings may lead to accountability for healthcare providers involved in the procurement process.
- If expired Remdesivir is confirmed to have been used, it could undermine public trust in health authorities.
- The inquiry could prompt stricter regulations on pharmaceutical procurement in Keralam.
Why it matters
The investigation could reveal serious implications for patient safety and pharmaceutical procurement practices.
Entities
Keralam· StateRemdesivir· DrugNipah Virus· VirusKozhikode Medical College· LocationKozhikode· City
Source
India Today
